• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹部肥胖与脂肪肝。

Abdominal obesity and fatty liver.

作者信息

Jakobsen M U, Berentzen T, Sørensen T I A, Overvad K

机构信息

Institute of Preventive Medicine, Centre for Health And Society, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Epidemiol Rev. 2007;29:77-87. doi: 10.1093/epirev/mxm002. Epub 2007 May 2.

DOI:10.1093/epirev/mxm002
PMID:17478441
Abstract

It has been hypothesized that visceral fat releases free fatty acids and adipokines and thereby exposes the liver to fat accumulation. The authors aimed to evaluate current epidemiologic evidence for an association between abdominal fat and liver fat content. Clinical and epidemiologic studies with data on abdominal fat and liver fat content were reviewed. Studies using waist circumference to estimate abdominal fat mass suggested a direct association between abdominal fat and liver fat content. Studies using imaging methods suggested a direct association between intraabdominal fat and liver fat content, but not between subcutaneous abdominal fat and liver fat content. In conclusion, clinical and epidemiologic studies of abdominal fat and liver fat content suggest a direct association between abdominal fat and liver fat content which is probably accounted for by visceral fat. However, results from the included studies do not allow strong conclusions regarding the temporal sequence of events. Future longitudinal studies are recommended to obtain additional information on associations and mechanisms. Both abdominal fat depots and other body compartments of interest should be included to further investigate the association between specific fat depots and liver fat content. Biomarkers may provide insight into underlying mechanisms.

摘要

有假说认为,内脏脂肪会释放游离脂肪酸和脂肪因子,从而使肝脏出现脂肪堆积。作者旨在评估目前关于腹部脂肪与肝脏脂肪含量之间关联的流行病学证据。对有腹部脂肪和肝脏脂肪含量数据的临床和流行病学研究进行了综述。使用腰围来估计腹部脂肪量的研究表明,腹部脂肪与肝脏脂肪含量之间存在直接关联。使用成像方法的研究表明,腹内脂肪与肝脏脂肪含量之间存在直接关联,但皮下腹部脂肪与肝脏脂肪含量之间不存在直接关联。总之,关于腹部脂肪与肝脏脂肪含量的临床和流行病学研究表明,腹部脂肪与肝脏脂肪含量之间存在直接关联,这可能是由内脏脂肪导致的。然而,纳入研究的结果无法就事件的时间顺序得出有力结论。建议未来进行纵向研究,以获取有关关联和机制的更多信息。应纳入腹部脂肪库和其他感兴趣的身体部位,以进一步研究特定脂肪库与肝脏脂肪含量之间的关联。生物标志物可能有助于深入了解潜在机制。

相似文献

1
Abdominal obesity and fatty liver.腹部肥胖与脂肪肝。
Epidemiol Rev. 2007;29:77-87. doi: 10.1093/epirev/mxm002. Epub 2007 May 2.
2
Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery.腹腔镜胃束带手术后病态肥胖患者肝脏脂肪含量变化的相关因素。
Diabetes Obes Metab. 2008 Aug;10(8):661-7. doi: 10.1111/j.1463-1326.2007.00793.x. Epub 2007 Oct 17.
3
Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage.二氮嗪可预防糖尿病前期肥胖OLETF大鼠的腹部肥胖和脂肪肝。
J Diabetes Complications. 2008 Jan-Feb;22(1):46-55. doi: 10.1016/j.jdiacomp.2006.08.005.
4
Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.脂肪酸在肥胖和脂肪肝发病机制中的作用:减肥手术的影响
Semin Liver Dis. 2008 Nov;28(4):407-26. doi: 10.1055/s-0028-1091985. Epub 2008 Oct 27.
5
Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.体重减轻对健康肥胖受试者内脏及腹部皮下脂肪组织血流和胰岛素介导的葡萄糖摄取的影响。
Ann Med. 2009;41(2):152-60. doi: 10.1080/07853890802446754.
6
Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery.胃束带手术后3个月和12个月时的腹部肥胖及肝脏脂肪含量
Metabolism. 2009 Jun;58(6):753-8. doi: 10.1016/j.metabol.2008.05.021.
7
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.非肥胖型非酒精性脂肪性肝病患者的营养调查:膳食胆固醇的意义
Scand J Gastroenterol. 2009;44(4):471-7. doi: 10.1080/00365520802588133.
8
Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms.显著体重减轻对内脏脂肪、肝脏脂肪变性和脂联素亚型的影响。
Eur J Clin Invest. 2008 Apr;38(4):238-44. doi: 10.1111/j.1365-2362.2008.01929.x. Epub 2008 Feb 26.
9
Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.内脏脂肪组织对肝脏代谢的影响。第一部分:脂肪组织的异质性及内脏脂肪组织的功能特性。
Diabetes Metab. 2008 Sep;34(4 Pt 1):317-27. doi: 10.1016/j.diabet.2008.04.001. Epub 2008 Jun 11.
10
Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.肝脏脂肪与β细胞功能或餐后游离脂肪酸反应无关。
Metabolism. 2009 Feb;58(2):196-203. doi: 10.1016/j.metabol.2008.09.013.

引用本文的文献

1
Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies.代谢功能障碍相关脂肪性肝病进展中的酮类代谢产物:优化酮治疗策略
Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E290-E301. doi: 10.1152/ajpendo.00178.2025. Epub 2025 Jul 7.
2
Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review.代谢功能障碍相关脂肪性肝病(MASLD)中果糖摄入的致病因素:一篇叙述性综述
Cell Stress. 2025 Jun 24;9:49-64. doi: 10.15698/cst2025.06.305. eCollection 2025.
3
Role of serum fasting glucagon in hypothyroidism-related nonalcoholic fatty liver disease.
血清空腹胰高血糖素在甲状腺功能减退症相关非酒精性脂肪性肝病中的作用。
Nutr Metab (Lond). 2025 Mar 11;22(1):19. doi: 10.1186/s12986-025-00899-z.
4
Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population.在中国人群中,内脏脂肪面积与骨骼肌质量之比的增加与代谢功能障碍相关脂肪性肝病的风险呈正相关。
Lipids Health Dis. 2024 Apr 14;23(1):104. doi: 10.1186/s12944-024-02100-5.
5
The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.中老年人群骨骼肌质量与内脏脂肪面积比值与代谢功能障碍相关脂肪性肝病亚型的关系:一项单中心回顾性研究
Front Nutr. 2023 Nov 8;10:1246157. doi: 10.3389/fnut.2023.1246157. eCollection 2023.
6
The relative contributions of soft tissue mass components as risk or protective factors of non-alcoholic fatty liver disease in children.儿童非酒精性脂肪性肝病的软组织质量成分的相对贡献作为风险或保护因素。
Eur J Clin Nutr. 2023 Dec;77(12):1167-1172. doi: 10.1038/s41430-023-01326-3. Epub 2023 Aug 16.
7
Relationship between liver fat content and lifestyle factors in adults with metabolic syndrome.代谢综合征成人的肝内脂肪含量与生活方式因素的关系。
Sci Rep. 2022 Oct 19;12(1):17428. doi: 10.1038/s41598-022-22361-3.
8
Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex.骨骼肌质量与内脏脂肪面积比值可预测瘦体重和超重男女的非酒精性脂肪肝,且性别存在调节作用。
Hepatol Commun. 2022 Sep;6(9):2238-2252. doi: 10.1002/hep4.1975. Epub 2022 May 3.
9
Visceral fat and arterial stiffness in youth with healthy weight, obesity, and type 2 diabetes.健康体重、肥胖和 2 型糖尿病青少年的内脏脂肪和动脉僵硬。
Pediatr Obes. 2022 Apr;17(4):e12865. doi: 10.1111/ijpo.12865. Epub 2021 Oct 19.
10
Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease.已知或疑似非酒精性脂肪性肝病患者内脏脂肪组织与非酒精性脂肪性肝炎组织学之间的关联
J Clin Med. 2021 Jun 10;10(12):2565. doi: 10.3390/jcm10122565.